These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8440739

  • 61. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
    Wang P, Brobey RK, Horii T, Sims PF, Hyde JE.
    Mol Microbiol; 1999 Jun; 32(6):1254-62. PubMed ID: 10383765
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.
    Mueller L, Hauser PM, Gauye F, Greub G.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137801
    [Abstract] [Full Text] [Related]

  • 65. Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.
    Lindsay DS, Butler JM, Rippey NS, Blagburn BL.
    Am J Vet Res; 1996 Jan; 57(1):68-72. PubMed ID: 8720241
    [Abstract] [Full Text] [Related]

  • 66. Cellular and molecular mechanisms of resistance to antifolate drugs: new analogues and approaches to overcome the resistance.
    Takemura Y, Kobayashi H, Miyachi H.
    Int J Hematol; 1997 Dec; 66(4):459-77. PubMed ID: 9479873
    [Abstract] [Full Text] [Related]

  • 67. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS, Galivan J, Wright JE, Rosowsky A.
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR, Johnson CA, Krauth CA, Carter RL, Hosmer CA, Queener SF, Borotz SE, Pfefferkorn ER.
    J Med Chem; 1996 Mar 15; 39(6):1271-80. PubMed ID: 8632434
    [Abstract] [Full Text] [Related]

  • 72. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW, Dreier J, Reinelt S, Bourne PC, Barrow WW.
    Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4447-52. PubMed ID: 17875993
    [Abstract] [Full Text] [Related]

  • 73. Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: part I.
    Gangjee A, Jain HD, Kurup S.
    Anticancer Agents Med Chem; 2007 Sep 15; 7(5):524-42. PubMed ID: 17896913
    [Abstract] [Full Text] [Related]

  • 74. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H, Takemura Y, Kobayashi H, Ando K, Ando Y.
    Jpn J Cancer Res; 1993 Jan 15; 84(1):9-12. PubMed ID: 8449831
    [Abstract] [Full Text] [Related]

  • 75. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
    Mareya SM, Sorrentino BP, Blakley RL.
    Cancer Gene Ther; 1998 Jan 15; 5(4):225-35. PubMed ID: 9694074
    [Abstract] [Full Text] [Related]

  • 76. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
    Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R, Lowe G, Thebtaranonth Y, Yuthavong Y.
    Bioorg Med Chem; 2000 May 15; 8(5):1117-28. PubMed ID: 10882022
    [Abstract] [Full Text] [Related]

  • 77. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D, Leartsakulpanich U, Chusacultanachai S, Yuthavong Y.
    Antimicrob Agents Chemother; 2007 Dec 15; 51(12):4356-60. PubMed ID: 17875995
    [Abstract] [Full Text] [Related]

  • 78. Biological and biochemical properties of new anticancer folate antagonists.
    Fry DW, Jackson RC.
    Cancer Metastasis Rev; 1987 Dec 15; 5(3):251-70. PubMed ID: 3549036
    [Abstract] [Full Text] [Related]

  • 79. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
    Matherly LH, Muench SP.
    Biochem Pharmacol; 1990 Jun 15; 39(12):2005-14. PubMed ID: 2141258
    [Abstract] [Full Text] [Related]

  • 80. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
    Roy K, Chiao JH, Spengler BA, Tolner B, Yang CH, Biedler JL, Sirotnak FM.
    Cancer Genet Cytogenet; 1998 Aug 15; 105(1):29-38. PubMed ID: 9689927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.